Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 6, 1997, Pages 781-788

  Nau, Roland ^a   Zysk, Gregor ^a   Schmidt, Holger ^a   Fischer, Falko R ^a   Stringaris, Argyris K ^a   Stuertz, Kristin ^a   Brück, Wolfgang ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALATROFLOXACIN; CEFTRIAXONE; INTERLEUKIN 1BETA; LACTIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL MENINGITIS; BACTERICIDAL ACTIVITY; CEREBROSPINAL FLUID CYTOLOGY; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; LEUKOCYTOSIS; NONHUMAN; RABBIT; SUBARACHNOID SPACE;

ADULT; ANIMALS; ANTI-INFECTIVE AGENTS; CEFTRIAXONE; CEPHALOSPORINS; DISEASE MODELS, ANIMAL; FLUOROQUINOLONES; HUMANS; INJECTIONS, INTRAVENOUS; INTERLEUKIN-1; LACTIC ACID; MENINGITIS, PNEUMOCOCCAL; NAPHTHYRIDINES; RABBITS; STREPTOCOCCUS PNEUMONIAE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030851283     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.6.781     Document Type: Article

References (36)

1. Mustafa, M. M., Ramilo. O., Mertsola, J., Risser, R. C., Beutler, B., Hansen, E. J. et al. (1989). Modulation of inflammation and cachectin activity in relation to treatment of experimental Haemophilus influenzae type b meningitis. Journal of Infectious Diseases 160, 818-25.
2. Tuomanen, E., Liu, H., Hengstler, B., Zak, O. & Tomasz, A. (1985). The induction of meningeal inflammation by components of the pneumococcal cell wall. Journal of Infectious Diseases 15, 859-68.
3. Burroughs, M., Prasad, S., Cabellos, C., Mendelman, P. M. & Tuomanen, E. (1993). The biologic activities of peptidoglycan in experimental Haemophilus influenzae meningitis. Journal of Infectious Diseases 167, 464-8.
4. Burroughs, M., Rozdzinski, E., Geelen, S. & Tuomanen, E. (1993). A structure-activity relationship for induction of meningeal inflammation by muramyl peptides. Journal of Clinical Investigation 92, 297-302.
5. Riesenfeld-Orn, I., Wolpe, S., Garcia-Bustos, J. F., Hoffmann, M. K. & Tuomanen, E. (1989). Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components. Infection and Immunity 57, 1890-3.
6. Stevens, D. L., Yan, S. & Bryant, A. E. (1993). Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect. Journal of Infectious Diseases 167, 1401-5.
7. Durand, M. L., Calderwood, S. B., Weber, D. J., Miller, S. I., Southwick, F. S., Caviness, V. S. et al. (1993). Acute bacterial meningitis in adults. A review of 493 episodes. New England Journal of Medicine 328, 21-8.
8. Dodge, P. R. & Swartz, M. N. (1965). Bacterial meningitis - a review of selected aspects. II. Special neurologic problems, postmeningitic complications and clinicopathological correlations. New England Journal of Medicine 272, 1003-10.
9. Syrogiannopoulos, G. A., Hansen, E. J., Erwin, A. L., Munford, R. S., Rutledge, J., Reisch, J. S. et al. (1988). Haemophilus influenzae type b lipooligosaccharide induces meningeal inflammation. Journal of Infectious Diseases 157, 237-44.
10. Täuber, M. G., Shibl, A. M., Hackbarth, C. J., Larrick, J. W. & Sande, M. A. (1987). Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits. Journal of Infectious Diseases 156, 456-62.
11. Quagliarello, V. & Scheld, W. M. (1992). Bacterial meningitis: pathogenesis, pathophysiology, and progress. New England Journal of Medicine 327, 864-72.
12. Townsend, G. C. & Scheld, W. M. (1993). Adjunctive therapy for bacterial meningitis: rationale for use, current status, and prospects for the future. Clinical Infectious Diseases 17, Suppl. 2, S5537-49.
13. Cabellos, C., Martinez-Lacasa, J., Martos, A., Tubau, F., Fernandez, A., Viladrich, P. F. et al. (1995). Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis. Antimicrobial Agents and Chemotherapy 39, 2158-60.
14. Paris, M. M., Hickey, S. M., Uscher, M. I., Shelton, S., Olsen, K. D. & McCracken, G. H. (1994). Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrobial Agents and Chemotherapy 38, 1320-4.
15. Kim, Y. S., Kennedy, S. & Täuber, M. G. (1995). Toxicity of Streptococcus pneumoniae in neurons, astrocytes, and microglia in vitro. Journal of Infectious Diseases 171, 1363-8.
16. Friedland, I. R., Paris, M., Ehrett, S., Hickey, S., Olsen, K. & McCracken, G. H. (1993). Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrobial Agents and Chemotherapy 37, 1630-6.
17. Nau, R., Schmidt, T., Kaye, K., Froula, J. L. & Täber, M. G. (1995). Quinolone antibiotics in therapy of experimental pneumococcal meningitis in rabbits. Antimicrobial Agents and Chemotherapy 39, 593-7.
18. Edelstein, P. H., Edelstein, M. A. C., Ren, J., Polzer, R. & Gladue, R. P. (1996). Activity of trovafloxacin (CP 99,219) against Legionella isolates: in vitro activity intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia. Antimicrobial Agents and Chemotherapy 40, 314-9.
19. Flick, D. A. & Gifford, G. E. (1984). Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. Journal of Immunological Methods 68, 167-75.
20. Zysk, G., Brück, W., Gerber, J., Brück, Y., Prange, H. W. & Nau, R. (1996). Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis. Journal of Neuropathology and Experimental Neurology 55, 722-8.
21. Gold, R., Schmied, M., Rothe, G., Zischler, H., Breitschopf, H., Wekerle, H. et al. (1993). Detection of DNA fragmentation in apoptosis: application of in situ nick translation to cell culture systems and tissue sections. Journal of Histochemistry and Cytochemistry 41, 1023-30.
22. Dofferhoff, A. S. M., Nijland, J. H., de Vires-Hospers, H. G., Mulder, P. O. M., Weits, J. & Bom, V. J. J. (1991). Effects of different types and combinations of antimicrobial agents on endotoxin release from Gram-negative bacteria: an in-vitro and in-vivo study. Scandinavian Journal of Infectious Diseases 23, 745-54.
23. Jackson, J. J. & Kropp, H. (1992). β-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. Journal of Infectious Diseases 165, 1033-41.
24. Prins, J. M., Kuijper, E. J., Mevissen, M. L., Speelman, P. & van Deventer, S. J. (1995). Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum. Infection and Immunity 63, 2236-42.
25. Mason, D. J., Power, E. G. M., Talsania, H., Phillips, I. & Gant, V. A. (1995). Antibacterial action of ciprofloxacin. Antimicrobial Agents and Chemotherapy 39, 2752-8.
26. Evans, M. E. & Pollack, M. (1993). Effect of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli. Journal of Infectious Diseases 167, 1336-43.
27. Friedland, I. R., Jafari, H., Ehrett, S., Rinderknecht, S., Paris, M., Coulthard, M. et al. (1993). Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis. Journal of Infectious Diseases 168, 657-62.
28. Hackbarth, C. J., Chambers, H. F., Stella, F., Shibl, A. M. & Sande, M. A. (1986). Ciprofloxacin in experimental Pseudomonas aeruginosa meningitis in rabbits. Journal of Antimicrobial Chemotherapy 18, Suppl. D, 65-9.
29. Shibl, A. M., Hackbarth, C. J., & Sande, M. A. (1986). Evaluation of pefloxacin in experimental Escherichia coli meningitis. Antimicrobial Agents and Chemotherapy 29, 409-11.
30. Visalli, M. A., Jacobs, M. R. & Appelbaum, P. C. (1996). Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology. Journal of Antimicrobial Chemotherapy 37, 77-84.
31. Teng, R., Harris, S. C., Nix, D. E., Schentag, J. J., Foulds, G. & Liston, T. E. (1995). Pharmacokinetics and safety of trovafloxacin (CP 99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers. Journal of Antimicrobial Chemotherapy 36, 385-94.
32. Small, P. M., Täuber, M. G., Hackbarth, C. J. & Sande, M. A. (1986). Influence of body temperature on bacterial growth rates in experimental pneumococcal meningitis in rabbits. Infection and Immunity 52, 484-7.
33. Eickhoff, T. C. & Ehret, J. (1981). Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative. Antimicrobial Agents and Chemotherapy 19, 435-42.
34. Neu, H. C. & Chin, N. X. (1994). In vitro activity of the new fluoroquinolone CP-99,219. Antimicrobial Agents and Chemotherapy 38, 2615-22.
35. Shalit, I. (1991). Immunological aspects of new quinolones. European Journal of Clinical Microbiology & Infectious Diseases 10, 262-6.
36. Guerra-Romero, L., Täuber, M. G., Fournier, M. A. & Tureen, J. H. (1992). Lactate and glucose concentrations in brain interstitial fluid, cerebrospinal fluid, and serum during experimental pneumococcal meningitis. Journal of Infectious Diseases 166, 546-50.